Gastroenterology

The accuracy of transient elastography following a sustained virologic response was considered poor.

FMT treatment was less effective for primary C difficile infections.

The FODMAP diet is considered a preferable option for patients with irritable bowel syndrome.

The machine learning model outperformed a comparison logistic regression model in identifying high-risk patients for HBV.

Most of Europe lacks an active and coordinated surveillance plan in place for monitoring hospital-acquired CDI.

Hospitals that use the 3-dose vaccine would spend approximately 37% more on prophylaxis for hepatitis B.

The evidence regarding patients with entecavir-treated chronic hepatitis B without maintaining virological response is limited and uncertain.

CDI rates remained down in 2020 despite an increase in antibiotic use during the pandemic.

Co-infections of HBV and HIV often lead to an increased risk of overall mortality.

The new assay was 100% on both sensitivity and specificity for detecting C difficile infections from rectal swabs.

Serum concentrations of aminotransferases improved for HCC-DAA and DAA-HCC groups 1 year following surgery.

One lot of the vancomycin kits mistakenly contained a first omeprazole diluent.

Grade 3 injection site redness led to the predefined stopping rules for 10 patients in the clinical trials.

More research is needed on the safety and efficacy of multiple biologics.

IBS is considered 1 of the most expensive conditions in gastroenterology.

Data show patients with chronic IBS had six times the odds of developing glaucoma (OR 6.58; 95% CI, 2.00 - 16.89), in comparison to those without chronic IBS.

Despite conflicting data, investigators form Spain found that gastroesophageal reflux disease and asthma are bidirectional, with each disease exacerbating each other.

CDI patients in the RT 014-020 subgroup had better clinical outcomes.

The Firmicutes/Bacteroidetes ratio was lower for patients with sickle cell disease compared to a healthy control group.

Fluoroquinolones use within 14 days of transplantation was 1 of the strongest risk factors for C difficile infections.

Clindamycin, fluoroquinolones, and ceftriaxone are associated with the highest risk of CDI.

Serum HBV DNA significantly decreased from week 0-24 in patients treated with entecavir.

The study also showed cost savings for both standard and dose-intensified infliximab.

Both patients and physicians request more time for routine ulcerative colitis appointments.

All NOACs had a lower risk of stroke or SE compared to warfarin, including apixaban, dabigatran, and rivaroxaban.